[kc_row use_container=”yes” force=”no” column_align=”middle” video_mute=”no” _id=”982725″][kc_column width=”12/12″ video_mute=”no” _id=”444187″][kc_column_text _id=”279305″]
2019 Novel Coronavirus (COVID-19) Pneumonia Serial Computed Tomography Findings-32100486
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)-32029004.pdf
Anesthetic Management of Patients Undergoing Aortic Dissection Repair With Suspected Severe Acute Respiratory Syndrome Coronavirus-2 Infection-32220557.pdf
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China-32211816.pdf
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)-2219357.pdf
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19). Evidence from a meta-analysis-32169400.pdf
Cardiovascualr disease, drug therapy and mortality in Covid-19-32356626.pdf
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic-32201335.pdf
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)-32219356.pdf
Cardiovascular system and COVID-19_ perspectives from a developing country-32380802.pdf
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic. From ACC's Interventional Council and SCAI-32199938.pdf
Chinese Society of Anesthesiology Expert Consensus on Anesthetic Management of Cardiac Surgical Patients With Suspected or Confirmed Coronavirus Disease 2019-32268984
CIRCULATIONAHA.120.047293.pdf
Consideraciones sobre el abordaje invasivo de la cardiopatía isquémica y estructural durante el brote de coronavirus COVID-19. Documento de consenso -SEC.pdf
Coronavirus Disease 2019 (COVID-19) Information for Cardiologists-Systematic Literature Review and Additional Analysis_32350235.pdf
COVID-19 and concerns regarding use of ACEi/ARB/ARNi medications for heart failure or hypertension-Can Cardiovasc Society_Use of ACEi ARB ARNi medicationr for heart failure or hypertension.pdf
covid-19 and the heart-32252591.pdf
COVID-19 and Thrombotic or Thromboembolic Disease Implications for Prevention, Antithrombotic Therapy, and Follow-up-State-of-the-Art Review.pdf
COVID-19 Clinical Guidance For the Cardiovascular Care Team_ACC Clinical Bulletin S20028-American Journal of Cardiology.pdf
COVID-19 Coronavirus- What Implications for Cardiology?-[italiano]-32202553.pdf
COVID-19 et maladies cardiovasculaires : ce que le fournisseur de soins de santé cardiaque doit savoir-COVID19 and Cardiovascular Disease-Canadian Cardiovascular Society-[francés].pdf
COVID‐19A Singapore Orthopedic resident’s musings in the Emergency Department-32198801.pdf
CSC Expert Consensus on Principles of Clinical Management of Patients with severe emergent cardiovascular diseases-32216640.pdf
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome-32297796.pdf
ECMO for ARDS Due to COVID-19-32223988.pdf
ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic_European Society Cardiology.pdf
Evidence Summary COVID-19 CardiopulmonaryResuscitation National Health Library and knowledge Service
Extracorporeal Membrane Oxygenation Therapy in the COVID-19 Pandemic-32301347.pdf
Fulminant myocarditis due to COVID-19_32345547.pdf
Gestión de las salas de procedimientos invasivos cardiológicos durante el brote de coronavirus COVID-19. Documento de consenso de la Asociación de Cardiología Intervencionista y la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología-10.24875/RECIC.M20000114.pdf
Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force-32247013.pdf
Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiología intervencionista en España. REC Interv Cardiol. 2020.pdf
Implicaciones de la pandemia por COVID-19 para el paciente con insuficiencia cardiaca, trasplante cardiaco y asistencia ventricular. Recomendaciones de la Asociación de Insuficiencia Cardiaca de la Sociedad Española de Cardiología.pdf
Inhibitors of the Renin-Angiotensin System_The Potential Role in the Pathogenesis of COVID-19-32286678.pdf
Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19_32356625.pdf
Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System-a Call for Epidemiologic Investigations-32215613.pdf
La COVID-19 et les préoccupations relatives à l’utilisation des médicaments cardiovasculaires, notamment les IECA, ARA et ARNI, l’AAS à faible dose et les anti-inflammatoires non stéroïdiens (AINS)_Mar20_FR-Société Canadienne de Cardiologie-[francés].pdf
Myocarditis in a patient with COVID-19_a cause of raised troponin and ECG changes-[In press].pdf
Myocarditis in a patient with COVID-19_a cause of raised troponin and ECG changes-[In press].pdf
Novel Coronavirus Pneumonia Outbreak in 2019Computed Tomographic Findings in Two Cases-32056397.pdf
Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy_32348640.pdf
Palliative Care Considerations For Patients With Cardiovascular Disease Under COVID-19 – American College of Cardiology.pdf
Potential Effects of Coronaviruses on the Cardiovascular System A Review-32219363.pdf
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China-32161990.pdf
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines_32316065 .pdf
Primary and Secondary Prevention of Cardiovascular Disease in the Era ofthe Coronavirus Pandemic-32310675.pdf
Recomendaciones ante una parada cardíaca durante la pandemia de COVID-19-Consejo Catalán de Reanimación Cardiopulmonar.pdf
Recomendaciones sobre el tratamiento antitrombótico durante durante la pandemia COVID-19-Pre-Proof.pdf
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19_32356627.pdf
Reperfusion of STEMI in the COVID-19 Era – Business as Usual-32282225
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)-32356863.pdf
Role of the American Heart Association in the Global COVID-19 Pandemic-32181680.pdf
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine-32327397.pdf
SARS-CoV-2 a potential novel etiology of fulminant myocarditis-32140732.pdf
SARS-CoV-2 Receptor ACE2-dependent Implications on the Cardiovascular System: From Basic Science to Clinical Implications_32360703.pdf
SARS-CoV2_Should Inhibitors of the Renin-Angiotensin System Be Withdrawn in Patients With COVID-19?-32196087.pdf
Special attention to nurses protection during the COVID-19 epidemic-32220243.pdf
The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease_32242886.pdf
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infectionsA meta-analysis-32178975.pdf
Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19 – American College of Cardiology.pdf
[/kc_column_text][/kc_column][/kc_row]
